Chang Xu

2.2k total citations
32 papers, 607 citations indexed

About

Chang Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chang Xu has authored 32 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Chang Xu's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Chang Xu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Chang Xu collaborates with scholars based in China, United States and Switzerland. Chang Xu's co-authors include Jianguo Cao, Mingyan Zhu, Qingsong Guo, Xiaocheng Cao, Yan Huang, Shajun Zhu, Yuhua Lu, Junfei Zhou, Xiang Li and Yinghong Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Chang Xu

30 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Xu China 14 372 215 171 68 50 32 607
Saswati N. Chand United States 11 375 1.0× 162 0.8× 195 1.1× 51 0.8× 35 0.7× 14 637
Nathalie Bauer Germany 14 432 1.2× 329 1.5× 246 1.4× 77 1.1× 39 0.8× 20 690
Yanping Li China 11 254 0.7× 218 1.0× 110 0.6× 59 0.9× 50 1.0× 34 483
Peiyan Hua China 15 367 1.0× 199 0.9× 87 0.5× 67 1.0× 65 1.3× 31 560
Yonggang Wang China 14 389 1.0× 288 1.3× 122 0.7× 60 0.9× 53 1.1× 30 660
Shuo Liang China 12 333 0.9× 184 0.9× 132 0.8× 65 1.0× 51 1.0× 30 623
Jia‐Hong Chen Taiwan 16 333 0.9× 159 0.7× 151 0.9× 82 1.2× 75 1.5× 29 625
Shengchao Lin China 11 296 0.8× 201 0.9× 74 0.4× 62 0.9× 69 1.4× 12 497

Countries citing papers authored by Chang Xu

Since Specialization
Citations

This map shows the geographic impact of Chang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Xu more than expected).

Fields of papers citing papers by Chang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Xu. The network helps show where Chang Xu may publish in the future.

Co-authorship network of co-authors of Chang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Xu. A scholar is included among the top collaborators of Chang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Xu. Chang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Qiong, Chang Xu, Mingqian Tan, et al.. (2025). Hydrogel‐Based Therapies for Photoaging: Current Advances and Future Perspectives. Journal of Cosmetic Dermatology. 24(6). e70295–e70295. 1 indexed citations
2.
3.
Zhang, Yao, Yao Zhang, Chang Xu, et al.. (2024). Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability. SHILAP Revista de lepidopterología. 7(6). 824–834. 2 indexed citations
4.
Xu, Chang, Jinfeng Cao, Yue Pei, et al.. (2024). Injectable hydrogel harnessing foreskin mesenchymal stem cell-derived extracellular vesicles for treatment of chronic diabetic skin wounds. Journal of Controlled Release. 370. 339–353. 8 indexed citations
5.
Xu, Kai, et al.. (2023). Activation of Nrf2 inhibits ferroptosis and protects against oxaliplatin-induced ototoxicity. Biomedicine & Pharmacotherapy. 165. 115248–115248. 14 indexed citations
6.
Chen, Yutong, et al.. (2022). Identification of immune infiltration landscape on prognosis and therapy of the ferroptosis-related genes signature in breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(11). 119328–119328. 2 indexed citations
7.
Xu, Chang, Hanji Fang, Yun Gu, et al.. (2022). Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer. Cancer Science. 113(12). 4070–4081. 10 indexed citations
8.
Huang, Kie Kyon, Jiawen Huang, Jeanie Wu, et al.. (2021). Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer. Genome biology. 22(1). 44–44. 50 indexed citations
9.
Qiu, Yong, Xueyuan Cao, Liu L, et al.. (2020). Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Li, Xiang, Xiaocheng Cao, Mengtao Zhou, et al.. (2020). Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p. Toxicology and Applied Pharmacology. 396. 114998–114998. 22 indexed citations
11.
Xu, Chang, Xiaocheng Cao, Xiaozheng Cao, et al.. (2020). Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression. Anti-Cancer Agents in Medicinal Chemistry. 20(14). 1654–1663. 12 indexed citations
12.
Yao, Ye, Qingyu Yao, Xiuyun Tian, et al.. (2020). Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor. Toxicology and Applied Pharmacology. 401. 115118–115118. 23 indexed citations
13.
Chen, An‐Tian, Chang Xu, Yimin Luo, et al.. (2019). Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1. Acta Biochimica et Biophysica Sinica. 51(12). 1267–1275. 13 indexed citations
14.
Lin, Meihua, et al.. (2018). Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 3101–3110. 57 indexed citations
15.
Xu, Chang, et al.. (2018). MicroRNA-96 is responsible for sevoflurane-induced cognitive dysfunction in neonatal rats via inhibiting IGF1R. Brain Research Bulletin. 144. 140–148. 27 indexed citations
16.
Cui, Li, et al.. (2017). Effects of different types of music on lactation performance and protein metabolism of dairy cows.. Guangdong nongye kexue. 29(5). 82–85. 2 indexed citations
17.
Zhou, Junfei, et al.. (2017). KLF15 regulates dopamine D2 receptor and participates in mouse models of neuropathic pain. Biochemical and Biophysical Research Communications. 492(2). 269–274. 9 indexed citations
18.
Wang, Lei, Yan Huang, Qingsong Guo, et al.. (2014). Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA. Diabetes Research and Clinical Practice. 104(3). 383–392. 22 indexed citations
19.
Lu, Yuhua, Hui Zhu, Haiyan Shan, et al.. (2013). Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Letters. 340(1). 113–123. 133 indexed citations
20.
Zhou, Shu‐Guang, et al.. (1997). [Mechanism of protective action of Phyllanthus urinaria L. against injuries of liver cells].. PubMed. 22(2). 109–11, inside back cover. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saswati N. Chand Breakdown of academic impact, for papers by Nathalie Bauer Breakdown of academic impact, for papers by Yanping Li Breakdown of academic impact, for papers by Peiyan Hua Breakdown of academic impact, for papers by Yonggang Wang Breakdown of academic impact, for papers by Shuo Liang Breakdown of academic impact, for papers by Jia‐Hong Chen Breakdown of academic impact, for papers by Shengchao Lin
Rankless by CCL
2026